Inovio Pharmaceuticals Inc banner

Inovio Pharmaceuticals Inc
NASDAQ:INO

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
NASDAQ:INO
Watchlist
Price: 1.74 USD
Market Cap: $120.2m

Wall Street
Price Targets

INO Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast INO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INO is 7.85 USD with a low forecast of 1.82 USD and a high forecast of 13.65 USD.

Lowest
Price Target
1.82 USD
4% Upside
Average
Price Target
7.85 USD
351% Upside
Highest
Price Target
13.65 USD
684% Upside
Inovio Pharmaceuticals Inc Competitors:
Price Targets
STRO
Sutro Biopharma Inc
57% Upside
EOLS
Evolus Inc
247% Upside
CALM
Cal-Maine Foods Inc
14% Upside
WINA
Winmark Corp
28% Upside

Revenue
Forecast

-30% / Year
Past Growth
1 293% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-30% / Year
Past Growth
1 293% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Inovio Pharmaceuticals Inc's revenue is -30%. The projected CAGR for the next 3 years is 1 293%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INO's stock price target?
Price Target
7.85 USD

According to Wall Street analysts, the average 1-year price target for INO is 7.85 USD with a low forecast of 1.82 USD and a high forecast of 13.65 USD.

What is Inovio Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
1 293%

For the last 14 years the compound annual growth rate for Inovio Pharmaceuticals Inc's revenue is -30%. The projected CAGR for the next 3 years is 1 293%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett